This chapter explores the scalability and cost challenges faced by the alternative protein industry, with a focus on Good Meat's approval to sell cultivated chicken in Singapore. It also discusses the potential threat posed by America's recent approval of cultivated meat production, while highlighting the positive impact of alternative protein options.
Ecuador and Guatemala faced similar preoccupations with violence and corruption—one of Ecuador’s candidates was assassinated on the campaign trail—but their electoral outcomes were very different. What does that reveal about the region? Once rare in America, leprosy is on the rise again, particularly in Florida (8:04). And how Singapore leads the charge for “alternative proteins” (14:08).
For full access to print, digital and audio editions of The Economist, try a free 30-day digital subscription by going to www.economist.com/intelligenceoffer